Dodwell, David
University of Oxford
3 papers on CoChatORCID 0000-0001-8787-4904
Most cited papers
- Verified
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
Coombes, R. C., Hall, E., Gibson, L. J., Paridaens, R., Jassem, J., Delozier, T., Jones, S. E., Alvarez, I., Bertelli, G., Ortmann, O., et al. (2004) · New England Journal of Medicine
Breast Cancer Treatment StudiesEstrogen and related hormone effects
Cited by 1,759
- Verified
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial
Johnston, S. R., Kilburn, L. S., Ellis, P., Dodwell, D., Cameron, D., Hayward, L., Im, Y.-H., Braybrooke, J. P., Brunt, A. M., Cheung, K.-L., et al. (2013) · The Lancet Oncology
Advanced Breast Cancer TherapiesBreast Cancer Treatment Studies
Cited by 274
- Verified
Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study
Clift, A. K., Dodwell, D., Lord, S., Petrou, S., Brady, M., Collins, G. S., & Hippisley-Cox, J. (2023) · BMJ
Breast Cancer Treatment StudiesGlobal Cancer Incidence and Screening
Cited by 97
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free